Members of the HESI Global Collaborative Effort to Revise ICH S7A will be attending the Society of Toxicologic Pathology 45th Annual Symposium.
Title: Points to Consider for Revising the ICH S7A Guideline on Safety and Secondary Pharmacology
Presenter: Derek Leishman, Eli Lilly & Company
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-8403
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.